The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021: Featured Updates to the NCCN Guidelines
Abstract
The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding factors with prognostic importance, and are intended to aid physicians with clinical decision-making. These NCCN Guidelines Insights focus on recent select updates to the NCCN Guidelines, including familial genetic alterations in AML, postinduction or postremission treatment strategies in low-risk acute promyelocytic leukemia or favorable-risk AML, principles surrounding the use of venetoclax-based therapies, and considerations for patients who prefer not to receive blood transfusions during treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., et al. (2017) · Blood · doi:10.1182/blood-2016-08-733196 · Cited by 5,775
Self-citationGenomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Mayer, R. J., Davis, R. B., Schiffer, C. A., Berg, D. T., Powell, B. L., Schulman, P., Omura, G. A., Moore, J. O., McIntyre, O. R., & Frei, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311402 · Cited by 1,427
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Schuurhuis, G. J., Heuser, M., Freeman, S., Béné, M.-C., Buccisano, F., Cloos, J., Grimwade, D., Haferlach, T., Hills, R. K., Hourigan, C. S., et al. (2018) · Blood · doi:10.1182/blood-2017-09-801498 · Cited by 1,041
Paschka, P., Marcucci, G., Ruppert, A. S., Mrózek, K., Chen, H., Kittles, R. A., Vukosavljevic, T., Perrotti, D., Vardiman, J. W., Carroll, A. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9500 · Cited by 663
Self-citationBurnett, A. K., Hills, R. K., Milligan, D., Kjeldsen, L., Kell, J., Russell, N. H., Yin, J. A. L., Hunter, A., Goldstone, A. H., & Wheatley, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4310 · Cited by 657
Shen, Z.-X., Shi, Z.-Z., Fang, J., Gu, B.-W., Li, J.-M., Zhu, Y.-M., Shi, J.-Y., Zheng, P.-Z., Yan, H., Liu, Y.-F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400053101 · Cited by 583
Burnett, A. K., Russell, N. H., Hills, R. K., Bowen, D., Kell, J., Knapper, S., Morgan, Y. G., Lok, J., Grech, A., Jones, G., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00193-x · Cited by 534
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms
Polprasert, C., Schulze, I., Sekeres, M. A., Makishima, H., Przychodzen, B., Hosono, N., Singh, J., Padgett, R. A., Gu, X., Phillips, J. G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.017 · Cited by 434
Self-citationYin, J. A. L., O'Brien, M. A., Hills, R. K., Daly, S. B., Wheatley, K., & Burnett, A. K. (2012) · Blood · doi:10.1182/blood-2012-06-435669 · Cited by 425
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D., Coutre, S. E., De Lima, M., Fathi, A. T., Fiorella, M., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0028 · Cited by 419
Self-citationEstey, E., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovsek, S., Jones, D., & Kantarjian, H. (2006) · Blood · doi:10.1182/blood-2005-10-4006 · Cited by 384
Ravandi, F., Estey, E., Jones, D., Faderl, S., O'Brien, S., Fiorentino, J., Pierce, S., Blamble, D., Estrov, Z., Wierda, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6130 · Cited by 376
Cairoli, R. (2006) · Blood · doi:10.1182/blood-2005-09-3640 · Cited by 375
Acute myeloid leukemia: 2019 update on risk‐stratification and management
Estey, E. H. (2018) · American Journal of Hematology · doi:10.1002/ajh.25214 · Cited by 371
Jourdan, E., Boissel, N., Chevret, S., Delabesse, E., Renneville, A., Cornillet, P., Blanchet, O., Cayuela, J.-M., Recher, C., Raffoux, E., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462879 · Cited by 363
Lo-Coco, F., Avvisati, G., Vignetti, M., Breccia, M., Gallo, E., Rambaldi, A., Paoloni, F., Fioritoni, G., Ferrara, F., Specchia, G., et al. (2010) · Blood · doi:10.1182/blood-2010-03-276196 · Cited by 332
Mutation of CEBPA in Familial Acute Myeloid Leukemia
Smith, M. L., Cavenagh, J. D., Lister, T. A., & Fitzgibbon, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041331 · Cited by 328
How I treat acute myeloid leukemia in the era of new drugs
DiNardo, C. D., & Wei, A. H. (2020) · Blood · doi:10.1182/blood.2019001239 · Cited by 290
Lewinsohn, M., Brown, A. L., Weinel, L. M., Phung, C., Rafidi, G., Lee, M. K., Schreiber, A. W., Feng, J., Babic, M., Chong, C.-E., et al. (2016) · Blood · doi:10.1182/blood-2015-10-676098 · Cited by 217
Self-citationGenomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
Churpek, J. E., Pyrtel, K., Kanchi, K.-L., Shao, J., Koboldt, D., Miller, C. A., Shen, D., Fulton, R., O’Laughlin, M., Fronick, C., et al. (2015) · Blood · doi:10.1182/blood-2015-04-641100 · Cited by 216
Disease evolution and outcomes in familial AML with germline CEBPA mutations
Tawana, K., Wang, J., Renneville, A., Bödör, C., Hills, R., Loveday, C., Savic, A., Van Delft, F. W., Treleaven, J., Georgiades, P., et al. (2015) · Blood · doi:10.1182/blood-2015-05-647172 · Cited by 201
Familial myelodysplasia and acute myeloid leukaemia – a review
Owen, C., Barnett, M., & Fitzgibbon, J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06909.x · Cited by 187
Jonas, B. A., & Pollyea, D. A. (2019) · Leukemia · doi:10.1038/s41375-019-0612-8 · Cited by 183
Self-citationEvaluating measurable residual disease in acute myeloid leukemia
Ravandi, F., Walter, R. B., & Freeman, S. D. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016378 · Cited by 162
Prognostic Impact of Minimal Residual Disease in CBFB-MYH11 –Positive Acute Myeloid Leukemia
Corbacioglu, A., Scholl, C., Schlenk, R. F., Eiwen, K., Du, J., Bullinger, L., Fröhling, S., Reimer, P., Rummel, M., Derigs, H. G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.6468 · Cited by 139
Sanders, M. A., Chew, E., Flensburg, C., Zeilemaker, A., Miller, S. E., Hinai, A. S. A. A., Bajel, A. R., Luiken, B., Rijken, M., McLennan, T. J., et al. (2018) · Blood · doi:10.1182/blood-2018-05-852566 · Cited by 135
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
Rio‐Machín, A., Vulliamy, T., Hug, N., Walne, A. J., Tawana, K., Cardoso, S. R., Ellison, A., Pontikos, N., Wang, J., Tummala, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14829-5 · Cited by 121
Fey, M. F., & Buske, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt320 · Cited by 119
Stahl, M. F., Shallis, R. M., Wei, W., Montesinos, P., Lengliné, É., Neukirchen, J., Bhatt, V. R., Sekeres, M. A., Fathi, A. T., Koenig, H., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0783-3 · Cited by 107
Self-citationBaliakas, P., Tesi, B., Wartiovaara‐Kautto, U., Stray‐Pedersen, A., Friis, L. S., Dybedal, I., Hovland, R., Jahnukainen, K., Raaschou‐Jensen, K., Ljungman, P. T., et al. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000321 · Cited by 98
Juliusson, G. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.02.003 · Cited by 93
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
Simon, L., Spinella, J.-F., Yao, C., Lavallée, V., Boivin, I., Boucher, G., Audemard, E. O., Bordeleau, M.-È., Lemieux, S., Hébert, J., et al. (2020) · Blood · doi:10.1182/blood.2019003357 · Cited by 93
Aldoss, I. T., Dadwal, S., Zhang, J., Tegtmeier, B., Mei, M. G., Arslan, S., Malki, M. M. A., Salhotra, A., Ali, H., Aribi, A. M., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000930 · Cited by 91
Self-citationHereditary Predispositions to Myelodysplastic Syndrome
Bannon, S. A., & Dinardo, C. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060838 · Cited by 76
Mei, M. G., Aldoss, I. T., Marcucci, G., & Pullarkat, V. A. (2018) · American Journal of Hematology · doi:10.1002/ajh.25369 · Cited by 63
Self-citationAplastic anemia and clonal evolution: germ line and somatic genetics
Shimamura, A. (2016) · Hematology · doi:10.1182/asheducation-2016.1.74 · Cited by 50
Ballen, K. K., Becker, P. S., Yeap, B. Y., Matthews, B. J., Henry, D. H., & Ford, P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.144 · Cited by 49
Stelljes, M., Corbacioglu, A., Schlenk, R. F., Döhner, K., Frühwald, M., Rössig, C., Ehlert, K., Silling, G., Müller‐Tidow, C., Juergens, H., et al. (2011) · Leukemia · doi:10.1038/leu.2011.64 · Cited by 35
Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients
Beck, A., Lin, R., Rejali, A. R., Rubens, M., PAQUETTE, R. L., Vescio, R. A., Merin, N. M., Guerrero, M., Federizo, Y., Lua, M., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0777-9 · Cited by 12
Treatment of acute leukaemia in adult Jehovah's Witnesses
Chaer, F. E., & Ballen, K. K. (2019) · British Journal of Haematology · doi:10.1111/bjh.16284 · Cited by 11
Cited by
Döhner, H., Wei, A. H., Appelbaum, F. R., Craddock, C., DiNardo, C. D., Dombret, H., Ebert, B. L., Fenaux, P., Godley, L. A., Hasserjian, R. P., et al. (2022) · Blood · doi:10.1182/blood.2022016867 · Cited by 3,279
Self-citationAdvances in acute myeloid leukemia
Newell, L. F., & Cook, R. J. (2021) · BMJ · doi:10.1136/bmj.n2026 · Cited by 440
Metadata
- Authors
- Pollyea, D. A., Bixby, D., Perl, A., Bhatt, V. R., Altman, J. K., Appelbaum, F. R., de Lima, M., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jacoby, M., Lancet, J., Mannis, G., Marcucci, G., Martin, M. G., Mims, A., Neff, J., Nejati, R., Olin, R., Percival, M.-E., Prebet, T., Przespolewski, A., Rao, D., Ravandi-Kashani, F., Shami, P. J., Stone, R. M., Strickland, S. A., Sweet, K., Vachhani, P., Wieduwilt, M., Gregory, K. M., Ogba, N., & Tallman, M. S.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2021-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 16-27
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3121021979
- Cited by
- 320
- References
- 46
- FWCI
- 34.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.